Paula M. Vertino, PhD


Titles and Roles

Professor Emeritus, Department of Radiation Oncology
Emory University School of Medicine
Research Program
Cancer Genetics and Epigenetics


Paula M. Vertino, PhD, is Professor Emeritus in the Department of Radiation Oncology at Emory University School of Medicine. Dr. Vertino is the Wilmot Distinguished Professor at the University of Rochester Medical Center in New York and serves as the Director of Translational Research and Professor of Biomedical Genetics at Wilmot Cancer Institute. At Emory, she served as leader of the Cancer Genetics and Epigenetics Program of Winship Cancer Institute. She also served as the Director of Graduate Studies for the Cancer Biology Graduate Program and was the co-director for research for the Hematology and Medical Oncology Fellowship Program.

Dr. Vertino is a cancer research scientist internationally recognized for her work in the field of cancer epigenetics. She has a longstanding record of extramural research support from the NCI, the American Cancer Society, NASA and the Georgia Cancer Coalition. She has served as a regular member on the Cancer Etiology study section at the NIH, and is a former member of the editorial board of Cancer Research.

While at Emory, Dr. Vertino was actively engaged in graduate and postgraduate education as well as trained and mentored numerous graduate students, postdoctoral fellows and medical residents in her laboratory.


Dr. Vertino pursued graduate work at the Roswell Park Cancer Institute, receiving her PhD from the State University of New York at Buffalo. After postdoctoral training in cancer genetics at the Johns Hopkins Oncology Center, Dr. Vertino joined the faculty of Emory University in 1996.


Dr. Vertino's research interests are focused on the areas of cancer epigenetics and novel mechanisms of gene silencing in cancer.


Dr. Vertino has published extensively on cancer epigenetics and novel mechanisms of gene silencing in cancer.

  • PublicationsPublication Date


Dr. Vertino received several awards including an Avon Breast Cancer Scholar Award for her work on the TMS1 gene and its role in breast carcinogenesis. She also received several local honors and awards, including induction into the 'Millipub Club' and the 'Emory 1%', recognizing Emory faculty that have authored articles cited more than 1000 times, and with NIH grants scoring in the top 1% at peer review. She was invited to the board of Faculty of 1000.

Cascade Link   TOP